Abstract
Study Objectives U-Sleep is a publicly-available automated sleep stager, but has not been independently validated using pediatric data. We aimed to a) test the hypothesis that U-Sleep performance is equivalent to trained humans, using a concordance dataset of 50 pediatric polysomnogram excerpts scored by multiple trained scorers, and b) identify clinical and demographic characteristics that impact U-Sleep accuracy, using a clinical dataset of 3114 polysomnograms from a tertiary center.
Methods Agreement between U-Sleep and ‘gold’ 30-second epoch sleep staging was determined across both datasets. Utilizing the concordance dataset, the hypothesis of equivalence between human scorers and U-Sleep was tested using a Wilcoxon two one-sided test (TOST). Multivariable regression and generalized additive modelling were used on the clinical dataset to estimate the effects of age, comorbidities and polysomnographic findings on U-Sleep performance.
Results The median (interquartile range) Cohen’s kappa agreement of U-Sleep and individual trained humans relative to “gold” scoring for 5-stage sleep staging in the concordance dataset were similar, kappa=0.79(0.19) vs 0.78(0.13) respectively, and satisfied statistical equivalence (TOST p<0.01). Median (interquartile range) kappa agreement between U-Sleep 2.0 and clinical sleep-staging was kappa=0.69(0.22). Modelling indicated lower performance for children <2 years, those with medical comorbidities possibly altering sleep electroencephalography (kappa reduction=0.07-0.15) and those with decreased sleep efficiency or sleep-disordered breathing (kappa reduction=0.1).
Conclusion While U-Sleep algorithms showed statistically equivalent performance to trained scorers, accuracy was lower in children <2 years and those with sleep-disordered breathing or comorbidities affecting electroencephalography. U-Sleep is suitable for pediatric clinical utilization provided automated staging is followed by expert clinician review.
Competing Interest Statement
Author Declarations: Ajay Kevat was financially supported by a Royal Australasian College of Physicians Research Entry Scholarship. Philip Terrill was financially supported by the National Health and Medical Research Council of Australia (Grants 2001729 and 2007001). Warren Ruehland is a Director of Respiratory Quality Assurance Pty Ltd, which provides the QSleep polysomnography inter-scorer reliability assessment service. The authors have no other relevant funding or conflict of interest disclosures.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Committee of Children's Health Queensland waived ethical approval for this work: EX/2022/QCHQ/87550
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author Declarations: Ajay Kevat was financially supported by a Royal Australasian College of Physicians Research Entry Scholarship. Philip Terrill was financially supported by the National Health and Medical Research Council of Australia (Grants 2001729 and 2007001). Warren Ruehland is a Director of Respiratory Quality Assurance Pty Ltd, which provides the QSleep polysomnography inter-scorer reliability assessment service. The authors have no other relevant funding or conflict of interest disclosures. All authors have seen and approved the manuscript.
Data Availability
Data produced in the present study are available upon reasonable request to the authors
